The pharmacokinetic interaction between TMC114, lopinavir and ritonavir, in HIV-1 infected subjects.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2004-004990-27-IT

Enrollment

Registered

2005-07-26

Start date

2005-05-09

Completion date

Unknown

Last updated

2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment of HIV-1 infected subjects

Interventions

Trade Name: NORVIR*336 CPS MOLLI 100 MG Product Name: NA Product Code: NA Pharmaceutical Form: Capsule, soft INN or Proposed INN: Ritonavir CAS Number: 155213-67-5 Concentration unit: mg milligram(s)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026